198 related articles for article (PubMed ID: 37435168)
1. Expert opinion on patient journey, diagnosis and clinical monitoring in acid sphingomyelinase deficiency in Turkey: a pediatric metabolic disease specialist's perspective.
Arslan N; Coker M; Gokcay GF; Kiykim E; Onenli Mungan HN; Ezgu F
Front Pediatr; 2023; 11():1113422. PubMed ID: 37435168
[TBL] [Abstract][Full Text] [Related]
2. Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective.
Erdem Ozdamar S; Koc AF; Durmus Tekce H; Kotan D; Ekmekci AH; Sengun IS; Yuceyar AN; Uluc K
Front Neurol; 2023; 14():1095134. PubMed ID: 37265469
[TBL] [Abstract][Full Text] [Related]
3. Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus.
Scarpa M; Barbato A; Bisconti A; Burlina A; Concolino D; Deodato F; Di Rocco M; Dionisi-Vici C; Donati MA; Fecarotta S; Fiumara A; Galeone C; Giona F; Giuffrida G; Manna R; Mariani P; Pession A; Scopinaro A; Spada M; Spandonaro F; Trifirò G; Carubbi F; Cappellini MD
Intern Emerg Med; 2023 Apr; 18(3):831-842. PubMed ID: 36882619
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic odyssey for patients with acid sphingomyelinase deficiency (ASMD): Exploring the potential indicators of diagnosis using quantitative and qualitative data.
Doerr A; Farooq M; Faulkner C; Gould R; Perry K; Pulikottil-Jacob R; Rajasekhar P
Mol Genet Metab Rep; 2024 Mar; 38():101052. PubMed ID: 38469089
[TBL] [Abstract][Full Text] [Related]
5. Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency.
McGovern MM; Dionisi-Vici C; Giugliani R; Hwu P; Lidove O; Lukacs Z; Eugen Mengel K; Mistry PK; Schuchman EH; Wasserstein MP
Genet Med; 2017 Sep; 19(9):967-974. PubMed ID: 28406489
[TBL] [Abstract][Full Text] [Related]
6. Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD).
McGovern MM; Avetisyan R; Sanson BJ; Lidove O
Orphanet J Rare Dis; 2017 Feb; 12(1):41. PubMed ID: 28228103
[TBL] [Abstract][Full Text] [Related]
7. Importance to include differential diagnostics for acid sphingomyelinase deficiency (ASMD) in patients suspected to have to Gaucher disease.
Oliva P; Schwarz M; Mechtler TP; Sansen S; Keutzer J; Prusa AR; Streubel B; Kasper DC
Mol Genet Metab; 2023 May; 139(1):107563. PubMed ID: 37086570
[TBL] [Abstract][Full Text] [Related]
8. Healthcare Service Use Patterns Among Patients with Acid Sphingomyelinase Deficiency Type B: A Retrospective US Claims Analysis.
Pulikottil-Jacob R; Ganz ML; Fournier M; Petruski-Ivleva N
Adv Ther; 2023 May; 40(5):2234-2248. PubMed ID: 36897522
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).
Wasserstein M; Dionisi-Vici C; Giugliani R; Hwu WL; Lidove O; Lukacs Z; Mengel E; Mistry PK; Schuchman EH; McGovern M
Mol Genet Metab; 2019 Feb; 126(2):98-105. PubMed ID: 30514648
[TBL] [Abstract][Full Text] [Related]
10. Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A/B).
Geberhiwot T; Wasserstein M; Wanninayake S; Bolton SC; Dardis A; Lehman A; Lidove O; Dawson C; Giugliani R; Imrie J; Hopkin J; Green J; de Vicente Corbeira D; Madathil S; Mengel E; Ezgü F; Pettazzoni M; Sjouke B; Hollak C; Vanier MT; McGovern M; Schuchman E
Orphanet J Rare Dis; 2023 Apr; 18(1):85. PubMed ID: 37069638
[TBL] [Abstract][Full Text] [Related]
11. Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis.
Cappellini MD; Motta I; Barbato A; Giuffrida G; Manna R; Carubbi F; Giona F
Eur J Intern Med; 2023 Feb; 108():81-84. PubMed ID: 36443133
[TBL] [Abstract][Full Text] [Related]
12. Chronic visceral acid sphingomyelinase deficiency (Niemann-Pick disease type B) in 16 Polish patients: long-term follow-up.
Lipiński P; Kuchar L; Zakharova EY; Baydakova GV; Ługowska A; Tylki-Szymańska A
Orphanet J Rare Dis; 2019 Feb; 14(1):55. PubMed ID: 30795770
[TBL] [Abstract][Full Text] [Related]
13. Acid Sphingomyelinase Deficiency: Sharing Experience of Disease Monitoring and Severity in France.
Mauhin W; Borie R; Dalbies F; Douillard C; Guffon N; Lavigne C; Lidove O; Brassier A
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207195
[TBL] [Abstract][Full Text] [Related]
14. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases.
Cassiman D; Packman S; Bembi B; Turkia HB; Al-Sayed M; Schiff M; Imrie J; Mabe P; Takahashi T; Mengel KE; Giugliani R; Cox GF
Mol Genet Metab; 2016 Jul; 118(3):206-213. PubMed ID: 27198631
[TBL] [Abstract][Full Text] [Related]
15. Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency.
Breilyn MS; Zhang W; Yu C; Wasserstein MP
Mol Genet Metab Rep; 2021 Sep; 28():100780. PubMed ID: 34285875
[TBL] [Abstract][Full Text] [Related]
16. Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency.
Raebel EM; Wiseman S; Donnelly C; Mathieson T; Pountney J; Crowe J; Hopkin J
Orphanet J Rare Dis; 2024 Feb; 19(1):36. PubMed ID: 38303068
[TBL] [Abstract][Full Text] [Related]
17. Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective.
Pinto C; Sousa D; Ghilas V; Dardis A; Scarpa M; Macedo MF
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884674
[TBL] [Abstract][Full Text] [Related]
18. Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.
Ezgu F; Alpsoy E; Bicik Bahcebasi Z; Kasapcopur O; Palamar M; Onay H; Ozdemir BH; Topcuoglu MA; Tufekcioglu O
Orphanet J Rare Dis; 2022 Mar; 17(1):90. PubMed ID: 35236382
[TBL] [Abstract][Full Text] [Related]
19. Case report: The spectrum of SMPD1 pathogenic variants in Hungary.
Molnar MJ; Szlepak T; Csürke I; Loth S; Káposzta R; Erdős M; Dezsőfi A
Front Genet; 2023; 14():1158108. PubMed ID: 37347058
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency.
Eskes ECB; van der Lienden MJC; Sjouke B; van Vliet L; Brands MMMG; Hollak CEM; Aerts JMFG
Mol Genet Metab; 2023 Aug; 139(4):107631. PubMed ID: 37453187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
